Cargando…
Association between Angiotensin-Converting Enzyme Inhibitors and Troponin in Acute Coronary Syndrome
BACKGROUND: Cardiovascular disease is the leading cause of mortality in the western world and its treatment should be optimized to decrease severe adverse events. OBJECTIVE: To determine the effect of previous use of angiotensin-converting enzyme inhibitors on cardiac troponin I measurement in patie...
Autores principales: | Minuzzo, Luiz, dos Santos, Elizabete Silva, Timerman, Ari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290742/ https://www.ncbi.nlm.nih.gov/pubmed/25590931 http://dx.doi.org/10.5935/abc.20140155 |
Ejemplares similares
-
Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment
Elevation Acute Coronary Syndrome
por: dos Santos, Elizabete Silva, et al.
Publicado: (2013) -
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?
por: Tscharre, Maximilian, et al.
Publicado: (2020) -
Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure
por: Chen, Runzhen, et al.
Publicado: (2022) -
Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010) -
Burning Mouth Syndrome Induced by Angiotensin-Converting Enzyme Inhibitors
por: Obara, Takafumi, et al.
Publicado: (2020)